View Past PerformanceThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsCloudMD Software & Services 대차대조표 건전성재무 건전성 기준 점검 1/6CloudMD Software & Services 의 총 주주 지분은 CA$28.6M 이고 총 부채는 CA$20.6M, 이는 부채 대 자기자본 비율을 72.3% 로 가져옵니다. 총자산과 총부채는 각각 CA$80.1M 및 CA$51.5M 입니다.핵심 정보72.26%부채/자본 비율CA$20.65m부채이자보상배율n/a현금CA$5.17m자본CA$28.57m총부채CA$51.53m총자산CA$80.10m최근 재무 건전성 업데이트공시 • Jul 12CloudMD Software & Services Inc. Common Shares to Be Deleted from OTC EquityCloudMD Software & Services Inc. Common Shares will be deleted from OTC Equity effective July 11, 2024, due to Acquisition /Merger /Amalgamation.공시 • Jul 10CloudMD Expects to Delist from TSX-V End of Trading on July 10CloudMD Software & Services Inc. (the ‘Company’ or ‘CloudMD’) and CPS Capital announced the successful completion of the previously announced go-private transaction (the ‘Transaction’) pursuant to which, among other things CPS Capital (through an affiliate) (‘CPS Capital’) acquired all of the issued and outstanding common shares of CloudMD (the ‘Shares’) by way of a court-approved plan of arrangement. Pursuant to the Transaction, CloudMD shareholders are entitled to receive a cash payment of CAD 0.04 per Share. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.모든 업데이트 보기Recent updates공시 • Jul 12CloudMD Software & Services Inc. Common Shares to Be Deleted from OTC EquityCloudMD Software & Services Inc. Common Shares will be deleted from OTC Equity effective July 11, 2024, due to Acquisition /Merger /Amalgamation.공시 • Jul 11CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital completed the acquisition of CloudMD Software & Services Inc. (TSXV:DOC).CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.9 million on May 14, 2024. Pursuant to the agreement, CPS has agreed to acquire all of the outstanding common shares of CloudMD for cash consideration of CAD 0.04 per share. The expected gross proceeds based the estimated CAD 0.04 per share reflects a CAD 12 million equity value before considering transactions costs. CPS Capital is funding the transaction through a combination of equity from its new flagship fund CPS Partners Fund V and its previous flagship fund CPS Partners Fund IV. Following completion of the transaction, the CloudMD shares will be delisted from the TSX Venture Exchange (the “TSXV”), and the Company will apply to cease to be a reporting issuer in applicable provinces in Canada. Under certain circumstances, CPS Capital is entitled to a CAD 3 million termination fee or an expense reimbursement to a maximum of CAD 1.75 million, and CloudMD is entitled to a CAD 1.75 million reverse termination fee. The transaction will be completed pursuant to a court-approved plan of arrangement under the Business Corporations Act (British Columbia). The transaction will be subject to the approval of at least: (i) 66 2/3% of the votes cast by shareholders; (ii) 66 2/3% of the votes cast by shareholders and option holders voting as a single class; and (iii) 50% of the votes cast by disinterested shareholders at a special meeting of CloudMD securityholders expected to be held before the end of June 2024. In addition to securityholder approval, the transaction is also subject to the receipt of certain regulatory approvals, the approval by Supreme Court of British Columbia and the TSX Venture exchange approval, Dissent Rights shall not have been validly exercised, and not withdrawn or deemed to have been withdrawn, with respect to more than 5% of the issued and outstanding Shares and other closing conditions customary in transactions of this nature. The transaction has been unanimously approved by the Board of Directors of the CloudMD following the unanimous recommendation of a special committee of independent directors of the CloudMD. The directors and executive officers of CloudMD, who collectively hold approximately 0.16% of the outstanding Shares and approximately 0.60% of the outstanding Shares and stock options collectively, entered into voting support agreements with CPS to support the transaction. The transaction is expected to be completed in July 2024. As of June 17, 2024, CloudMD Software & Services Inc. is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co., two leading independent proxy advisory firms, have each recommended that CloudMD shareholders vote “FOR” the proposed go-private transaction of CloudMD with 1480775 B.C. Ltd., an affiliate of CPS Capital LP pursuant to a plan of arrangement under the Business Corporations Act. As of June 27, 2024, CloudMD securityholders approved Go-Private transaction with CPS Capital. On July 3, 2024, CloudMD received a final order from the Supreme Court of British Columbia approving the transaction. As of July 3, 2024 the arrangement is expected to close on or about July 9, 2024. INFOR Financial has provided an opinion to the Special Committee. INFOR Financial is acting as the exclusive strategic and financial advisor to CloudMD and Frank Arnone and Lindsay Clements of Cassels Brock & Blackwell LLP is acting as legal counsel to CloudMD in connection with the transaction. Paul De Luca of Owens Wright LLP is acting as legal counsel to CPS Capital in connection with the transaction. CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital completed the acquisition of CloudMD Software & Services Inc. (TSXV:DOC) on July 9, 2024. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.공시 • Jul 10CloudMD Expects to Delist from TSX-V End of Trading on July 10CloudMD Software & Services Inc. (the ‘Company’ or ‘CloudMD’) and CPS Capital announced the successful completion of the previously announced go-private transaction (the ‘Transaction’) pursuant to which, among other things CPS Capital (through an affiliate) (‘CPS Capital’) acquired all of the issued and outstanding common shares of CloudMD (the ‘Shares’) by way of a court-approved plan of arrangement. Pursuant to the Transaction, CloudMD shareholders are entitled to receive a cash payment of CAD 0.04 per Share. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.공시 • May 18Cloudmd Software & Services Inc. Announces Executive ResignationsCloudMD Software & Services Inc. announced that Bram Lowsky, EVP, Head, Health and Wellness Services, has resigned as an officer of CloudMD and that Dhruv Chandra, Chief Technology Officer, will depart from the Company on May 23, 2024.공시 • May 17+ 1 more updateCPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.7 million.CPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.7 million on May 15, 2024. Pursuant to the agreement, CPS has agreed to acquire all of the outstanding common shares of CloudMD for cash consideration of CAD 0.04 per share. The expected gross proceeds based the estimated CAD 0.04 per share reflects a CAD 12 million equity value before considering transactions costs. CPS Capital is funding the transaction through a combination of equity from its new flagship fund CPS Partners Fund V and its previous flagship fund CPS Partners Fund IV. Following completion of the transaction, the CloudMD shares will be delisted from the TSX Venture Exchange (the “TSXV”), and the Company will apply to cease to be a reporting issuer in applicable provinces in Canada. Under certain circumstances, CPS Capital is entitled to a $3 million (CAD 4.1 million) termination fee or an expense reimbursement to a maximum of $1.5 million (CAD 2.05 million), and CloudMD is entitled to a $1.75 million (CAD 2.391060 million) reverse termination fee. The transaction will be completed pursuant to a court-approved plan of arrangement under the Business Corporations Act (British Columbia). The transaction will be subject to the approval of at least: (i) 66 2/3% of the votes cast by shareholders; (ii) 66 2/3% of the votes cast by shareholders and optionholders voting as a single class; and (iii) 50% of the votes cast by disinterested shareholders at a special meeting of CloudMD securityholders expected to be held before the end of June 2024. In addition to securityholder approval, the transaction is also subject to the receipt of certain regulatory approvals, the approval by Supreme Court of British Columbia and the TSX Venture exchange approval and other closing conditions customary in transactions of this nature. The transaction has been unanimously approved by the Board of Directors of the CloudMD following the unanimous recommendation of a special committee of independent directors of the CloudMD. The directors and executive officers of CloudMD, who collectively hold approximately 0.16% of the outstanding Shares and approximately 0.60% of the outstanding Shares and stock options collectively, entered into voting support agreements with CPS to support the transaction. The transaction is expected to be completed in July 2024. INFOR Financial has provided an opinion to the Special Committee. INFOR Financial is acting as the exclusive strategic and financial advisor to CloudMD and Cassels Brock & Blackwell LLP is acting as legal counsel to CloudMD in connection with the transaction. Owens Wright LLP is acting as legal counsel to CPS Capital in connection with the transaction.공시 • Nov 30Cloudmd Software & Services Inc. Provides Revenue Guidance for the Fourth Quarter of 2023CloudMD Software & Services Inc. provided revenue guidance for the fourth quarter of 2023. For the period, the company expects low double-digit revenue growth in 2023 based on the fourth quarter of 2023 forecast compared to the fourth quarter of 2022.공시 • Nov 11CloudMD Software & Services Inc. to Report Q3, 2023 Results on Nov 23, 2023CloudMD Software & Services Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 23, 2023공시 • Sep 26CloudMD Software & Services Inc., Annual General Meeting, Dec 15, 2023CloudMD Software & Services Inc., Annual General Meeting, Dec 15, 2023. Location: Cassels Brock & Blackwell LLP, Suite 3200, Bay Adelaide Centre-North Tower, 40 Temperance Street, Toronto Ontario Canada Agenda: Annual & Special Meeting.공시 • Aug 29Cloudmd Software & Services Inc. Provides Earnings Guidance for the Year 2023CloudMD Software & Services Inc. providedearnings guidance for the year 2023. For the year, the Company expects low double digit revenue growth in 2023 based on the fourth quarter of 2023 forecast compared to the fourth quarter of 2022.공시 • Aug 16CloudMD Software & Services Inc. to Report Q2, 2023 Results on Aug 28, 2023CloudMD Software & Services Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 28, 2023공시 • Jul 07CloudMD Software & Services Inc. Shares Results of Ontario Therapist Assisted Internet Delivered Cognitive Behavioural Therapy ProgramCloudMD Software & Services Inc. released the findings of a research report on the health outcomes delivered by CloudMD Therapist-Assisted Internet-Delivered Cognitive Behavioural Therapy program which was offered to the public of Ontario as part of the government's pandemic response. This program is digitally delivered to help treat prevalent mental health challenges, including mood and anxiety conditions. By eliminating barriers to care - including time to treatment, accessibility, and stigma - CloudMD's TAiCBT program, MindBeacon, met the needs of some 65,000 Ontarians during the COVID-19 pandemic, thanks to the support from the Ontario government. This initiative provided innovative made-in-Canada virtual services that served as an effective and economical model for the rest of the country. Key highlights from the report include: Faster time to treatment - average time to start treatment of five days compared to weeks or months; More flexible access to care - 90% of patients engaged outside traditional office hours; Cost effective - TAiCBT is 1/5th the cost of traditional treatment; Health Outcomes with effective treatment for all ages, genders, protocols and symptom severities - 60% of patients with clinically severe depression symptoms experienced reliable symptom improvement; Improvements in Health equity - 32% of patients identify as racialized persons reflecting the diverse population of Ontario; Effective for first time treatment - 51% of patients were new to therapy and accessed support for the first time.공시 • Jul 06N. Harris Computer Corporation acquired Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) for $6.3 million.N. Harris Computer Corporation acquired Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) for $6.3 million on July 4, 2023. Approximately $5.5 million of the consideration was paid on closing (subject to adjustments for working capital) with the balance held as a customary holdback. INFOR Financial Inc. acted as exclusive financial advisor and Cassels Brock & Blackwell LLP acted as legal advisor to CloudMD.N. Harris Computer Corporation completed the acquisition of Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) on July 4, 2023.공시 • Jun 08+ 4 more updatesCloudMD Software & Services Inc. Reaffirms Earnings Guidance for the Year 2023CloudMD Software & Services Inc. reaffirmed earnings guidance for the year 2023. The company reaffirmed its guidance, provided on first quarter of 2023 earnings call dated May 30, 2023.공시 • Jun 01+ 1 more updateCloudMD Software & Services Inc. Provides Revenue Guidance for the Year 2023CloudMD Software & Services Inc. provided revenue guidance for the year 2023. The company expects low double digit revenue growth in 2023 from the fourth quarter 2022 baseline.공시 • May 25CloudMD Software & Services Inc. to Report Q1, 2023 Results on May 29, 2023CloudMD Software & Services Inc. announced that they will report Q1, 2023 results After-Market on May 29, 2023공시 • Feb 15CloudMDakes Mental Health More Accessible with Launch of Spanish Language TAiCBT in the United StatesCloudMD Software & Services Inc. announced the launch of its Spanish language therapist-assisted internet-based Cognitive Behavioral Therapy ("TAiCBT") as part of its mental health offering in the United States. English and Spanish EAP and TAiCBT are delivered through CloudMD's mental health brand Harmony Health in the United States. Spanish TAiCBT is being launched for many longstanding customers and for new clients like Venetian Resorts. Over 20% of adults in the U.S. experience mental illness. It is a large and growing problem, and with the average cost of therapy between $100 and $200 per session, there are barriers to receiving help. Innovative solutions like TAiCBTreduces the cost, eliminates barriers, and is often as clinically effective as traditional therapy. For employers the return on investment is clear with 86% of employers indicating that mental health resources help increase employee retention. Preventative mental wellness programs have been shown to save between $2 and $4 dollars for every one dollar invested.공시 • Feb 10CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of 51% stake in West Mississauga Medical Ltd.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical Ltd. for CAD 0.2 million on June 14, 2020. As on August 13, 2020, CloudMD Software & Services Inc. entered into a share purchase agreement to acquire 51% stake in West Mississauga Medical Ltd. Under the terms of consideration, CAD 0.14 millions payable in cash and CAD 0.06 million in shares of CloudMD Software & Services Inc. The consideration shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. West Mississauga Medical generated more than CAD 1.8 million in revenues with earnings before interest, taxes, depreciation, and amortization EBITDA margins exceeding 11% over the last fiscal year ending December 2019. West Mississauga Medical will be integrated into the CloudMD EMR platform and its network of doctors and specialists will immediately start servicing CloudMD’s registered users and patients in Ontario. As part of the transaction, Sohal Goyal, has been appointed as a Head of Corporate Development in Ontario by CloudMD. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before July 31, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of 51% stake in West Mississauga Medical Ltd. on February 9, 2021.공시 • Jan 29CloudMD Software & Services Inc. Appoints Kristine Heckman as VP Clinic OperationsCloudMD Software & Services Inc. announced that it has appointed a new VP, Clinic Operations to integrate and lead its current network of clinics and continue driving expansion across every province of Canada and strategically in the United States. Kristine Heckman is joining CloudMD as VP Clinic Operations and is the latest addition to the Company’s management team. Kristine brings over 20 years of industry experience, most recently as VP, Clinic Operations with Lifemark Health, a national rehabilitation company with over 200 locations across Canada.공시 • Jan 28CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc. for CAD 9.5 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc. (collectively “Rxi”) for CAD 9.5 million on January 26, 2021. In consideration for the purchase of 100% of the outstanding securities of Rxi, CloudMD has agreed to pay shareholders of Rxi aggregate consideration of CAD 9.5 million payable as follows: (i) CAD 2.5 million in cash, subject to a working capital adjustment; (ii) CAD 4 million in common shares of the Company; and (iii) a performance-based earnout of CAD 3 million, which is payable in common shares of the Company in equal annual issuances over a period of two years. The common shares will be subject to certain contractual restrictions on trading for a period of 20 months from the date of issuance. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval.공시 • Jan 23CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Canadian Medical Directory from Owen Media Partners Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Canadian Medical Directory from Owen Media Partners Inc. for approximately CAD 2 million on October 21, 2020. Pursuant to the transaction, CloudMD has agreed to pay aggregate consideration of CAD 2 million payable as follows: (i) CAD 0.25 million in cash; (ii) CAD 1.35 million in shares of CloudMD; and (iii) a performance-based earnout of CAD 0.350 million, which is payable in shares of CloudMD in annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.35 per share and are priced by calculating the 10-day volume-weighted average trading price of CloudMD' shares for the 10 trading days prior to the execution of the binding term sheet. The shares will be subject to certain contractual restrictions on trading for a period of 16 months from the date of issuance. The acquisition of CMD is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSXV approval. The acquisition of Canadian Medical Directory will be immediately accretive to CloudMD’s top line with the 100% SaaS and high margin revenue model. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Canadian Medical Directory from Owen Media Partners Inc. on January 22, 2021. As of January 22, 2021, aggregate consideration of approximately CAD 2.037 million paid as follows: (i) CAD 0.25 million in cash; (ii) approximately CAD 1.42 million in shares of the CloudMD; and (iii) a performance-based earnout of CAD 0.368 million, which is payable in shares of the CloudMD in annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.47 per share and are priced by calculating the 10-day volume-weighted average trading price of the CloudMD shares for the 10 trading days prior to the execution of the binding term sheet. For the 12 month period ending September 30, 2020, Canadian Medical Directory reported approximately CAD 0.293 million in EBITDA.공시 • Jan 20CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Aspiria Corp. for CAD 3 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Aspiria Corp. for CAD 3 million on January 18, 2021. As part of the consideration, CloudMD has agreed to pay shareholders of Aspiria aggregate consideration of CAD 3 million payable as follows: (i) CAD 1.2 million in cash, subject to a working capital adjustment; (ii) CAD 1.05 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 0.75 million, which is payable in common shares of the CloudMD after a period of 1 year. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of Aspiria will be immediately accretive to CloudMD with synergies the company believes will drive further revenue and increased EBITDA margins throughout its Enterprise Health Service division.공시 • Jan 17CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Medical Confidence Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Medical Confidence Inc. for CAD 6 million on October 22, 2020. In consideration for the purchase of 100% of the outstanding securities of Medical Confidence, CloudMD has agreed to pay shareholders aggregate consideration of CAD 6.7 million payable as follows: (i) CAD 2.25 million in cash, subject to a working capital adjustment; (ii) CAD 2.25 million in shares of the company; and (iii) a performance-based earnout of CAD 1.5 million, which is payable 50% in shares of the company and 50% in cash in equal annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.625 per share and are priced by calculating the 10-day volume-weighted average trading price of the company's shares for the 10 trading days prior to the execution of the binding term sheet. The shares will be subject to certain contractual restrictions on trading for a period of 20 months from the date of issuance. Medical Confidence generated approximately CAD 2 million in revenues with EBITDA margins exceeding 26% over the last fiscal year ending March 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. The transaction is expected to close before November 30, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Medical Confidence Inc. on January 15, 2021. CloudMD Software & Services signed as share purchase agreement to acquire Medical Confidence on December 10, 2020. CloudMD Software & Services made cash payment of CAD 2.25 million and issued 857,143 common shares on closing, and a performance based earnout payment will be payable by CAD 0.75 million in cash and issuance of 285,714 common shares. Medical Confidence will be integrated into CloudMD’s platform of Enterprise Solutions.공시 • Jan 13CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of HumanaCare Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million on October 28, 2020. As part of the consideration, CloudMD has agreed to pay (i) CAD 6.3 million in cash, subject to a working capital adjustment, (ii) CAD 6.825 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 4.375 million, which is payable in common shares of the CloudMD in equal annual issuances over a period of two years. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of HumanaCare will be immediately accretive to CloudMD with synergies the CloudMD believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses and other healthcare professionals. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of HumanaCare Inc. on January 12, 2021. CloudMD Software & Services Inc. believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses, and other healthcare professionals.공시 • Dec 19CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire IDYA4 for $14.8 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire IDYA4 for $14.8 million on December 17, 2020. Pursuant to the transaction, CloudMD has agreed to pay aggregate consideration of $14.8 million payable as follows (i) $3.7 million in cash, subject to a working capital adjustment; (ii) $6.7 million in common shares of CloudMD; and (iii) a performance based earnout of $4.4 million, of which $0.4 million is payable in cash and $4 million is payable in common shares of CloudMD in equal annual issuances over a period of two years. 30% of the total consideration for the acquisition amounting to $4.4 million is based on two performance based earnouts, 15% each, that are contingent on meeting the forecasted revenue targets. All common shares issued pursuant to the acquisition are issued at a deemed price of $2.16 per share and are priced by calculating the 10-day volume-weighted average trading price of CloudMD'S shares for the 10 trading days prior to the execution of the binding term sheet. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of IDYA4 will be immediately accretive to CloudMD with synergies the company believes will drive further revenue and increased EBITDA margin through cost savings achieved through the scaling of operations and by tapping into CloudMD's current health technology solutions that will be added to IDYA4’s current product portfolio.공시 • Nov 20CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Re:Function Health Group Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8.3 million on August 19, 2020. As of November 9, 2020, CloudMD Software & Services signed a definitive share purchase agreement to acquire Re:Function Health Group Inc. As per terms, consideration is paid in the form of CAD 3 million in cash, subject to a working capital adjustment, CAD 3.5 million in the form of issue of common shares and CAD 1.5 million earn out which is payable in shares of CloudMD in annual issuances over a period of three years. The shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. As per the approval, consideration paid CAD 3 million in cash, 3.977272 million of common shares, and 1.704546 million common shares in the form of performance based earn out. Ralph Cheesman and Mike Smith will be joining CloudMD to lead the continued expansion of allied health services across North America. Re:Function group of clinics generated approximately CAD 5.8 million in revenues with earnings before interest, taxes, depreciation and amortization margins exceeding 19% over the last fiscal year ending January, 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. As of November 12, 2020, TSX Venture Exchange has accepted for filing a Binding Term Sheet. The company anticipates a definitive agreement on or before September 18, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Re:Function Health Group Inc on November 19, 2020.공시 • Nov 10CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 32.4 million.CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 32.4 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 13,500,000 Price\Range: CAD 2.4 Discount Per Security: CAD 0.168공시 • Oct 29CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million on October 28, 2020. As part of the consideration, CloudMD has agreed to pay (i) CAD 6.3 million in cash, subject to a working capital adjustment, (ii) CAD 6.825 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 4.375 million, which is payable in common shares of the CloudMD in equal annual issuances over a period of two years. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of HumanaCare will be immediately accretive to CloudMD with synergies the CloudMD believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses and other healthcare professionals.공시 • Oct 20+ 1 more updateCloudMD Software &Services Inc. Appoints Mena Beshay as Global Head, Corporate DevelopmentCloudMD Software &Services Inc. announced that it has appointed Mena Beshay, the Company's current Chief Financial Officer ("CFO"), to a newly created, more focused role of Global Head, Corporate Development, where he will be responsible for leading the Company's corporate development activities which includes global mergers and acquisitions ("M&A") and its organic growth strategy. Mena's financial and operational experience will be valuable in leading the execution of the Company's growth strategy, while putting an even greater emphasis on M&A.공시 • Oct 16CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Snapclarity Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Snapclarity Inc. for CAD 6.8 million on July 16, 2020. CloudMD Software & Services Inc. has signed an Amalgamation Agreement to acquire Snapclarity Inc. on September 22, 2020. Total consideration payable by CloudMD in connection with the acquisition is CAD 3.35 million, subject to certain holdbacks, payable as up to CAD 0.98 million in cash and up to CAD 2.38 million in shares of CloudMD. All shares issued pursuant to the acquisition are subject to a two year release. Additionally, subject to the achievement of certain performance conditions in 2021 and 2022, Snapclarity may earn an additional CAD 3.65 million in equity-based consideration. Snapclarity will amalgamate with a wholly-owned subsidiary of CloudMD and upon completion of the Amalgamation, the amalgamated corporation will be a wholly-owned subsidiary of CloudMD. The Amalgamation is subject to Snapclarity shareholder approval. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before August 14, 2020. The transaction is expected to close before September 30, 2020. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Snapclarity Inc. on October 15, 2020.공시 • Oct 10CloudMD Software & Services Launches CloudMD On Demand, a National, Online Telemedicine Service for Pharmacies, Insurance Companies and EmployersCloudMD Software & Services Inc. announced the launch of a new service: CloudMD On Demand, an online, virtual care service for companies, insurers and pharmacies to offer their customers easier, more convenient access to virtual telemedicine. CloudMD OnDemand aims to provide turnkey and readily accessible virtual healthcare options to enterprise level partners. Through the offering, CloudMD develops a white-labeled, customizable landing page where individuals can get access to a doctor on demand for non-emergency medical appointments. This offering is especially important for employers, insurance providers and pharmacies, who have been instrumental in the development of this service. In addition, corporations with e-commerce websites can streamline the process for customers to see a doctor online and refill a prescription for pick up at a pharmacy location of their choice, or have it delivered directly to their doorstep. COVID-19 has increased the need for access to care through digital platforms, and employers are looking for evidence based, outcome-oriented solutions that will offer virtual healthcare for employees and their family members. Equally important is that the healthcare provided virtually, is delivered by physicians with the same level of patient care compared to an in person visit in a clinic. CloudMD uses public healthcare resources to ensure the highest quality of care and treatment plans for patients. The availability of the on-demand service is important for partners to continue managing the wellbeing of their customers and employees. The on-demand platform also eliminates the disruption in continuity of care caused by limited healthcare resources due to the pandemic. Patients are able to receive cost effective and efficient care, while empowering them to take control of their healthcare.공시 • Sep 29CloudMD Software & Services Inc. (TSXV:DOC) entered into a Binding Term Sheet to acquire 87.5% stake in Benchmark Systems, Inc. from Antworks Pte. Ltd. for $4.4 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a Binding Term Sheet to acquire 87.5% stake in Benchmark Systems, Inc. from Antworks Pte. Ltd. for $4.4 million on September 28, 2020. As per the terms, CloudMD will pay $4.4 million in cash. AntWorks will retain a 12.5% equity stake in Benchmark. As a minority holder of Benchmark, AntWorks will continue to work with CloudMD providing expertise in global hyper automation and AI and provide access to cutting edge AI technologies. In the fiscal year ending March 31, 2020, Benchmark generated approximately $4.9 million in revenues. Approximately 80% of revenue was SAAS based, recurring revenue. EBITDA is 13% annually from SAAS based, recurring revenue. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement. CloudMD anticipates a definitive agreement on or before October 15, 2020. The purchase of Benchmark will be immediately accretive to CloudMD and provides a number of opportunities for optimization to drive further revenue.공시 • Sep 26+ 1 more updateCanada Health Infoway and CloudMD Partner to Give More Canadians Access to e-PrescribingCanada Health Infoway (Infoway) and CloudMD announce that they have reached an agreement to advance e-prescribing in Canada. PrescribeIT® is Infoway's national e-prescribing service that enables prescribers and pharmacists to electronically create, receive, renew and cancel prescriptions, while improving overall patient care through secure clinician messaging. Under the agreement, CloudMD will integrate its Juno electronic medical record (EMR) with PrescribeIT's solution infrastructure. Cloud MD is aiming to have the technical work completed in early 2021. Once complete, physicians and nurse practitioners who offer virtual consultations with patients will be able to send prescriptions electronically from their EMR to the patient's pharmacy of choice, and pharmacies will be able to request prescription renewals electronically from the patient's prescriber. CloudMD provides virtual medical care to a combined network of 376 clinics, more than 3,000 licensed practitioners and almost three million patients through its technology components.공시 • Sep 24CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 18.078 million.CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 18.078 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 13,100,000 Price\Range: CAD 1.38 Discount Per Security: CAD 0.0966공시 • Sep 18CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding agreement to acquire Chronic Care Medical Clinic.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding agreement to acquire Chronic Care Medical Clinic on August 5, 2020. The acquisition is subject to customary closing conditions and receipt of TSX Venture Exchange approval. Terms of the agreement will be disclosed upon signing of the definitive agreement. CloudMD Software & Services anticipates closing of the acquisition on or before September 8, 2020.공시 • Aug 25CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8 million on August 24, 2020. As per terms, consideration is paid in the form of CAD 3 million in cash, CAD 3.5 million in the form of issue of common shares and CAD 1.5 million earn out which is payable in shares of CloudMD in annual issuances over a period of three years. The shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. Ralph Cheesman and Mike Smith will be joining CloudMD. Re:Function group of clinics generated approximately CAD 5.8 million in revenues with earnings before interest, taxes, depreciation and amortization margins exceeding 19% over the last fiscal year ending January, 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. The company anticipates a definitive agreement on or before September 18, 2020. The acquisition will be immediately accretive to CloudMD.공시 • Aug 06CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of South Surrey Medical Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet agreement to acquire South Surrey Medical Inc. for CAD 0.7 million on June 11, 2020. The parties entered into a share purchase agreement on July 28, 2020. CloudMD Software & Services Inc. has agreed to pay an aggregate consideration of up to CAD 0.7 million payable as up to CAD 0.2 million in cash and up to CAD 0.5 million in shares of CloudMD Software & Services Inc., a portion of which is subject to the achievement of certain performance conditions, and a customary working capital adjustment. All shares issued pursuant to the acquisition are priced at the ten-day volume weighted trading price of the Company shares for the 10 trading days prior to the execution of the definitive agreement. South Surrey Medical generated revenue of CAD 3 million in the latest fiscal year ended December 31, 2019. South Surrey Medical operates with 24 healthcare professionals. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD Software & Services Inc. anticipates a definitive agreement on or before July 31, 2020. As on July 28, 2020, CloudMD anticipates closing of the acquisition on or before July 31, 2020. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of South Surrey Medical Inc. on August 5, 2020.공시 • Jul 30CloudMD Software & Services Inc. (CNSX:DOC) acquired Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd.CloudMD Software & Services Inc. (CNSX:DOC) acquired Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd. on July 17, 2019. CloudMD Software & Services Inc. (CNSX:DOC) completed the acquisition of Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd. on July 17, 2019.공시 • Jun 17CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical for CAD 0.2 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical for CAD 0.2 million on June 16, 2020. Under the terms of consideration, CAD 0.14 millions payable in cash and CAD 0.06 million in shares of CloudMD Software & Services Inc. West Mississauga Medical generated more than CAD 1.8 million in revenues. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before July 31, 2020. The acquisition will be immediately accretive to CloudMD.재무 상태 분석단기부채: DOCR.F 의 단기 자산 ( CA$31.7M )은 단기 부채( CA$41.0M ).장기 부채: DOCR.F의 단기 자산(CA$31.7M)이 장기 부채(CA$10.6M)를 초과합니다.부채/자본 비율 추이 및 분석부채 수준: DOCR.F 의 순부채 대 자기자본 비율( 54.2% )은 높음으로 간주됩니다.부채 감소: DOCR.F의 부채 대비 자본 비율은 지난 5년 동안 30.4%에서 72.3%로 증가했습니다.대차대조표현금 보유 기간 분석과거에 평균적으로 손실을 기록해 온 기업의 경우, 최소 1년 이상의 현금 보유 기간이 있는지 평가합니다.안정적인 현금 활주로: DOCR.F 현재 무료 현금 흐름을 기준으로 1년 미만의 cash runway를 보유하고 있습니다.예측 현금 활주로: 무료 현금 흐름이 매년 34 %의 역사적 비율로 계속 감소할 경우 DOCR.F 의 현금 활주로는 1년 미만입니다.건전한 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 건실한 기업.View Dividend기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/07/09 05:48종가2024/07/09 00:00수익2024/03/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CloudMD Software & Services Inc.는 6명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Gabriel LeungBeacon Securities LimitedPrasath PanduranganBloom Burton & Co.Douglas TaylorCanaccord Genuity3명의 분석가 더 보기
공시 • Jul 12CloudMD Software & Services Inc. Common Shares to Be Deleted from OTC EquityCloudMD Software & Services Inc. Common Shares will be deleted from OTC Equity effective July 11, 2024, due to Acquisition /Merger /Amalgamation.
공시 • Jul 10CloudMD Expects to Delist from TSX-V End of Trading on July 10CloudMD Software & Services Inc. (the ‘Company’ or ‘CloudMD’) and CPS Capital announced the successful completion of the previously announced go-private transaction (the ‘Transaction’) pursuant to which, among other things CPS Capital (through an affiliate) (‘CPS Capital’) acquired all of the issued and outstanding common shares of CloudMD (the ‘Shares’) by way of a court-approved plan of arrangement. Pursuant to the Transaction, CloudMD shareholders are entitled to receive a cash payment of CAD 0.04 per Share. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.
공시 • Jul 12CloudMD Software & Services Inc. Common Shares to Be Deleted from OTC EquityCloudMD Software & Services Inc. Common Shares will be deleted from OTC Equity effective July 11, 2024, due to Acquisition /Merger /Amalgamation.
공시 • Jul 11CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital completed the acquisition of CloudMD Software & Services Inc. (TSXV:DOC).CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.9 million on May 14, 2024. Pursuant to the agreement, CPS has agreed to acquire all of the outstanding common shares of CloudMD for cash consideration of CAD 0.04 per share. The expected gross proceeds based the estimated CAD 0.04 per share reflects a CAD 12 million equity value before considering transactions costs. CPS Capital is funding the transaction through a combination of equity from its new flagship fund CPS Partners Fund V and its previous flagship fund CPS Partners Fund IV. Following completion of the transaction, the CloudMD shares will be delisted from the TSX Venture Exchange (the “TSXV”), and the Company will apply to cease to be a reporting issuer in applicable provinces in Canada. Under certain circumstances, CPS Capital is entitled to a CAD 3 million termination fee or an expense reimbursement to a maximum of CAD 1.75 million, and CloudMD is entitled to a CAD 1.75 million reverse termination fee. The transaction will be completed pursuant to a court-approved plan of arrangement under the Business Corporations Act (British Columbia). The transaction will be subject to the approval of at least: (i) 66 2/3% of the votes cast by shareholders; (ii) 66 2/3% of the votes cast by shareholders and option holders voting as a single class; and (iii) 50% of the votes cast by disinterested shareholders at a special meeting of CloudMD securityholders expected to be held before the end of June 2024. In addition to securityholder approval, the transaction is also subject to the receipt of certain regulatory approvals, the approval by Supreme Court of British Columbia and the TSX Venture exchange approval, Dissent Rights shall not have been validly exercised, and not withdrawn or deemed to have been withdrawn, with respect to more than 5% of the issued and outstanding Shares and other closing conditions customary in transactions of this nature. The transaction has been unanimously approved by the Board of Directors of the CloudMD following the unanimous recommendation of a special committee of independent directors of the CloudMD. The directors and executive officers of CloudMD, who collectively hold approximately 0.16% of the outstanding Shares and approximately 0.60% of the outstanding Shares and stock options collectively, entered into voting support agreements with CPS to support the transaction. The transaction is expected to be completed in July 2024. As of June 17, 2024, CloudMD Software & Services Inc. is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co., two leading independent proxy advisory firms, have each recommended that CloudMD shareholders vote “FOR” the proposed go-private transaction of CloudMD with 1480775 B.C. Ltd., an affiliate of CPS Capital LP pursuant to a plan of arrangement under the Business Corporations Act. As of June 27, 2024, CloudMD securityholders approved Go-Private transaction with CPS Capital. On July 3, 2024, CloudMD received a final order from the Supreme Court of British Columbia approving the transaction. As of July 3, 2024 the arrangement is expected to close on or about July 9, 2024. INFOR Financial has provided an opinion to the Special Committee. INFOR Financial is acting as the exclusive strategic and financial advisor to CloudMD and Frank Arnone and Lindsay Clements of Cassels Brock & Blackwell LLP is acting as legal counsel to CloudMD in connection with the transaction. Paul De Luca of Owens Wright LLP is acting as legal counsel to CPS Capital in connection with the transaction. CPS Partners Fund IV, CPS Partners Fund V, funds managed by CPS Capital completed the acquisition of CloudMD Software & Services Inc. (TSXV:DOC) on July 9, 2024. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.
공시 • Jul 10CloudMD Expects to Delist from TSX-V End of Trading on July 10CloudMD Software & Services Inc. (the ‘Company’ or ‘CloudMD’) and CPS Capital announced the successful completion of the previously announced go-private transaction (the ‘Transaction’) pursuant to which, among other things CPS Capital (through an affiliate) (‘CPS Capital’) acquired all of the issued and outstanding common shares of CloudMD (the ‘Shares’) by way of a court-approved plan of arrangement. Pursuant to the Transaction, CloudMD shareholders are entitled to receive a cash payment of CAD 0.04 per Share. The Shares are expected to be delisted from the TSX Venture Exchange after the end of trading on July 10, 2024. CPS Capital intends to cause CloudMD to submit an application to cease to be a reporting issuer under applicable Canadian securities laws.
공시 • May 18Cloudmd Software & Services Inc. Announces Executive ResignationsCloudMD Software & Services Inc. announced that Bram Lowsky, EVP, Head, Health and Wellness Services, has resigned as an officer of CloudMD and that Dhruv Chandra, Chief Technology Officer, will depart from the Company on May 23, 2024.
공시 • May 17+ 1 more updateCPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.7 million.CPS Capital entered into a definitive arrangement agreement to acquire CloudMD Software & Services Inc. (TSXV:DOC) for CAD 12.7 million on May 15, 2024. Pursuant to the agreement, CPS has agreed to acquire all of the outstanding common shares of CloudMD for cash consideration of CAD 0.04 per share. The expected gross proceeds based the estimated CAD 0.04 per share reflects a CAD 12 million equity value before considering transactions costs. CPS Capital is funding the transaction through a combination of equity from its new flagship fund CPS Partners Fund V and its previous flagship fund CPS Partners Fund IV. Following completion of the transaction, the CloudMD shares will be delisted from the TSX Venture Exchange (the “TSXV”), and the Company will apply to cease to be a reporting issuer in applicable provinces in Canada. Under certain circumstances, CPS Capital is entitled to a $3 million (CAD 4.1 million) termination fee or an expense reimbursement to a maximum of $1.5 million (CAD 2.05 million), and CloudMD is entitled to a $1.75 million (CAD 2.391060 million) reverse termination fee. The transaction will be completed pursuant to a court-approved plan of arrangement under the Business Corporations Act (British Columbia). The transaction will be subject to the approval of at least: (i) 66 2/3% of the votes cast by shareholders; (ii) 66 2/3% of the votes cast by shareholders and optionholders voting as a single class; and (iii) 50% of the votes cast by disinterested shareholders at a special meeting of CloudMD securityholders expected to be held before the end of June 2024. In addition to securityholder approval, the transaction is also subject to the receipt of certain regulatory approvals, the approval by Supreme Court of British Columbia and the TSX Venture exchange approval and other closing conditions customary in transactions of this nature. The transaction has been unanimously approved by the Board of Directors of the CloudMD following the unanimous recommendation of a special committee of independent directors of the CloudMD. The directors and executive officers of CloudMD, who collectively hold approximately 0.16% of the outstanding Shares and approximately 0.60% of the outstanding Shares and stock options collectively, entered into voting support agreements with CPS to support the transaction. The transaction is expected to be completed in July 2024. INFOR Financial has provided an opinion to the Special Committee. INFOR Financial is acting as the exclusive strategic and financial advisor to CloudMD and Cassels Brock & Blackwell LLP is acting as legal counsel to CloudMD in connection with the transaction. Owens Wright LLP is acting as legal counsel to CPS Capital in connection with the transaction.
공시 • Nov 30Cloudmd Software & Services Inc. Provides Revenue Guidance for the Fourth Quarter of 2023CloudMD Software & Services Inc. provided revenue guidance for the fourth quarter of 2023. For the period, the company expects low double-digit revenue growth in 2023 based on the fourth quarter of 2023 forecast compared to the fourth quarter of 2022.
공시 • Nov 11CloudMD Software & Services Inc. to Report Q3, 2023 Results on Nov 23, 2023CloudMD Software & Services Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 23, 2023
공시 • Sep 26CloudMD Software & Services Inc., Annual General Meeting, Dec 15, 2023CloudMD Software & Services Inc., Annual General Meeting, Dec 15, 2023. Location: Cassels Brock & Blackwell LLP, Suite 3200, Bay Adelaide Centre-North Tower, 40 Temperance Street, Toronto Ontario Canada Agenda: Annual & Special Meeting.
공시 • Aug 29Cloudmd Software & Services Inc. Provides Earnings Guidance for the Year 2023CloudMD Software & Services Inc. providedearnings guidance for the year 2023. For the year, the Company expects low double digit revenue growth in 2023 based on the fourth quarter of 2023 forecast compared to the fourth quarter of 2022.
공시 • Aug 16CloudMD Software & Services Inc. to Report Q2, 2023 Results on Aug 28, 2023CloudMD Software & Services Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 28, 2023
공시 • Jul 07CloudMD Software & Services Inc. Shares Results of Ontario Therapist Assisted Internet Delivered Cognitive Behavioural Therapy ProgramCloudMD Software & Services Inc. released the findings of a research report on the health outcomes delivered by CloudMD Therapist-Assisted Internet-Delivered Cognitive Behavioural Therapy program which was offered to the public of Ontario as part of the government's pandemic response. This program is digitally delivered to help treat prevalent mental health challenges, including mood and anxiety conditions. By eliminating barriers to care - including time to treatment, accessibility, and stigma - CloudMD's TAiCBT program, MindBeacon, met the needs of some 65,000 Ontarians during the COVID-19 pandemic, thanks to the support from the Ontario government. This initiative provided innovative made-in-Canada virtual services that served as an effective and economical model for the rest of the country. Key highlights from the report include: Faster time to treatment - average time to start treatment of five days compared to weeks or months; More flexible access to care - 90% of patients engaged outside traditional office hours; Cost effective - TAiCBT is 1/5th the cost of traditional treatment; Health Outcomes with effective treatment for all ages, genders, protocols and symptom severities - 60% of patients with clinically severe depression symptoms experienced reliable symptom improvement; Improvements in Health equity - 32% of patients identify as racialized persons reflecting the diverse population of Ontario; Effective for first time treatment - 51% of patients were new to therapy and accessed support for the first time.
공시 • Jul 06N. Harris Computer Corporation acquired Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) for $6.3 million.N. Harris Computer Corporation acquired Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) for $6.3 million on July 4, 2023. Approximately $5.5 million of the consideration was paid on closing (subject to adjustments for working capital) with the balance held as a customary holdback. INFOR Financial Inc. acted as exclusive financial advisor and Cassels Brock & Blackwell LLP acted as legal advisor to CloudMD.N. Harris Computer Corporation completed the acquisition of Non-Core US Electronic Medical Records & Practice Management Business of CloudMD Software & Services from CloudMD Software & Services Inc. (TSXV:DOC) on July 4, 2023.
공시 • Jun 08+ 4 more updatesCloudMD Software & Services Inc. Reaffirms Earnings Guidance for the Year 2023CloudMD Software & Services Inc. reaffirmed earnings guidance for the year 2023. The company reaffirmed its guidance, provided on first quarter of 2023 earnings call dated May 30, 2023.
공시 • Jun 01+ 1 more updateCloudMD Software & Services Inc. Provides Revenue Guidance for the Year 2023CloudMD Software & Services Inc. provided revenue guidance for the year 2023. The company expects low double digit revenue growth in 2023 from the fourth quarter 2022 baseline.
공시 • May 25CloudMD Software & Services Inc. to Report Q1, 2023 Results on May 29, 2023CloudMD Software & Services Inc. announced that they will report Q1, 2023 results After-Market on May 29, 2023
공시 • Feb 15CloudMDakes Mental Health More Accessible with Launch of Spanish Language TAiCBT in the United StatesCloudMD Software & Services Inc. announced the launch of its Spanish language therapist-assisted internet-based Cognitive Behavioral Therapy ("TAiCBT") as part of its mental health offering in the United States. English and Spanish EAP and TAiCBT are delivered through CloudMD's mental health brand Harmony Health in the United States. Spanish TAiCBT is being launched for many longstanding customers and for new clients like Venetian Resorts. Over 20% of adults in the U.S. experience mental illness. It is a large and growing problem, and with the average cost of therapy between $100 and $200 per session, there are barriers to receiving help. Innovative solutions like TAiCBTreduces the cost, eliminates barriers, and is often as clinically effective as traditional therapy. For employers the return on investment is clear with 86% of employers indicating that mental health resources help increase employee retention. Preventative mental wellness programs have been shown to save between $2 and $4 dollars for every one dollar invested.
공시 • Feb 10CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of 51% stake in West Mississauga Medical Ltd.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical Ltd. for CAD 0.2 million on June 14, 2020. As on August 13, 2020, CloudMD Software & Services Inc. entered into a share purchase agreement to acquire 51% stake in West Mississauga Medical Ltd. Under the terms of consideration, CAD 0.14 millions payable in cash and CAD 0.06 million in shares of CloudMD Software & Services Inc. The consideration shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. West Mississauga Medical generated more than CAD 1.8 million in revenues with earnings before interest, taxes, depreciation, and amortization EBITDA margins exceeding 11% over the last fiscal year ending December 2019. West Mississauga Medical will be integrated into the CloudMD EMR platform and its network of doctors and specialists will immediately start servicing CloudMD’s registered users and patients in Ontario. As part of the transaction, Sohal Goyal, has been appointed as a Head of Corporate Development in Ontario by CloudMD. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before July 31, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of 51% stake in West Mississauga Medical Ltd. on February 9, 2021.
공시 • Jan 29CloudMD Software & Services Inc. Appoints Kristine Heckman as VP Clinic OperationsCloudMD Software & Services Inc. announced that it has appointed a new VP, Clinic Operations to integrate and lead its current network of clinics and continue driving expansion across every province of Canada and strategically in the United States. Kristine Heckman is joining CloudMD as VP Clinic Operations and is the latest addition to the Company’s management team. Kristine brings over 20 years of industry experience, most recently as VP, Clinic Operations with Lifemark Health, a national rehabilitation company with over 200 locations across Canada.
공시 • Jan 28CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc. for CAD 9.5 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc. (collectively “Rxi”) for CAD 9.5 million on January 26, 2021. In consideration for the purchase of 100% of the outstanding securities of Rxi, CloudMD has agreed to pay shareholders of Rxi aggregate consideration of CAD 9.5 million payable as follows: (i) CAD 2.5 million in cash, subject to a working capital adjustment; (ii) CAD 4 million in common shares of the Company; and (iii) a performance-based earnout of CAD 3 million, which is payable in common shares of the Company in equal annual issuances over a period of two years. The common shares will be subject to certain contractual restrictions on trading for a period of 20 months from the date of issuance. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval.
공시 • Jan 23CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Canadian Medical Directory from Owen Media Partners Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Canadian Medical Directory from Owen Media Partners Inc. for approximately CAD 2 million on October 21, 2020. Pursuant to the transaction, CloudMD has agreed to pay aggregate consideration of CAD 2 million payable as follows: (i) CAD 0.25 million in cash; (ii) CAD 1.35 million in shares of CloudMD; and (iii) a performance-based earnout of CAD 0.350 million, which is payable in shares of CloudMD in annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.35 per share and are priced by calculating the 10-day volume-weighted average trading price of CloudMD' shares for the 10 trading days prior to the execution of the binding term sheet. The shares will be subject to certain contractual restrictions on trading for a period of 16 months from the date of issuance. The acquisition of CMD is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSXV approval. The acquisition of Canadian Medical Directory will be immediately accretive to CloudMD’s top line with the 100% SaaS and high margin revenue model. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Canadian Medical Directory from Owen Media Partners Inc. on January 22, 2021. As of January 22, 2021, aggregate consideration of approximately CAD 2.037 million paid as follows: (i) CAD 0.25 million in cash; (ii) approximately CAD 1.42 million in shares of the CloudMD; and (iii) a performance-based earnout of CAD 0.368 million, which is payable in shares of the CloudMD in annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.47 per share and are priced by calculating the 10-day volume-weighted average trading price of the CloudMD shares for the 10 trading days prior to the execution of the binding term sheet. For the 12 month period ending September 30, 2020, Canadian Medical Directory reported approximately CAD 0.293 million in EBITDA.
공시 • Jan 20CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Aspiria Corp. for CAD 3 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Aspiria Corp. for CAD 3 million on January 18, 2021. As part of the consideration, CloudMD has agreed to pay shareholders of Aspiria aggregate consideration of CAD 3 million payable as follows: (i) CAD 1.2 million in cash, subject to a working capital adjustment; (ii) CAD 1.05 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 0.75 million, which is payable in common shares of the CloudMD after a period of 1 year. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of Aspiria will be immediately accretive to CloudMD with synergies the company believes will drive further revenue and increased EBITDA margins throughout its Enterprise Health Service division.
공시 • Jan 17CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Medical Confidence Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire Medical Confidence Inc. for CAD 6 million on October 22, 2020. In consideration for the purchase of 100% of the outstanding securities of Medical Confidence, CloudMD has agreed to pay shareholders aggregate consideration of CAD 6.7 million payable as follows: (i) CAD 2.25 million in cash, subject to a working capital adjustment; (ii) CAD 2.25 million in shares of the company; and (iii) a performance-based earnout of CAD 1.5 million, which is payable 50% in shares of the company and 50% in cash in equal annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of CAD 2.625 per share and are priced by calculating the 10-day volume-weighted average trading price of the company's shares for the 10 trading days prior to the execution of the binding term sheet. The shares will be subject to certain contractual restrictions on trading for a period of 20 months from the date of issuance. Medical Confidence generated approximately CAD 2 million in revenues with EBITDA margins exceeding 26% over the last fiscal year ending March 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. The transaction is expected to close before November 30, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Medical Confidence Inc. on January 15, 2021. CloudMD Software & Services signed as share purchase agreement to acquire Medical Confidence on December 10, 2020. CloudMD Software & Services made cash payment of CAD 2.25 million and issued 857,143 common shares on closing, and a performance based earnout payment will be payable by CAD 0.75 million in cash and issuance of 285,714 common shares. Medical Confidence will be integrated into CloudMD’s platform of Enterprise Solutions.
공시 • Jan 13CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of HumanaCare Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million on October 28, 2020. As part of the consideration, CloudMD has agreed to pay (i) CAD 6.3 million in cash, subject to a working capital adjustment, (ii) CAD 6.825 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 4.375 million, which is payable in common shares of the CloudMD in equal annual issuances over a period of two years. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of HumanaCare will be immediately accretive to CloudMD with synergies the CloudMD believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses and other healthcare professionals. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of HumanaCare Inc. on January 12, 2021. CloudMD Software & Services Inc. believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses, and other healthcare professionals.
공시 • Dec 19CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire IDYA4 for $14.8 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire IDYA4 for $14.8 million on December 17, 2020. Pursuant to the transaction, CloudMD has agreed to pay aggregate consideration of $14.8 million payable as follows (i) $3.7 million in cash, subject to a working capital adjustment; (ii) $6.7 million in common shares of CloudMD; and (iii) a performance based earnout of $4.4 million, of which $0.4 million is payable in cash and $4 million is payable in common shares of CloudMD in equal annual issuances over a period of two years. 30% of the total consideration for the acquisition amounting to $4.4 million is based on two performance based earnouts, 15% each, that are contingent on meeting the forecasted revenue targets. All common shares issued pursuant to the acquisition are issued at a deemed price of $2.16 per share and are priced by calculating the 10-day volume-weighted average trading price of CloudMD'S shares for the 10 trading days prior to the execution of the binding term sheet. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of IDYA4 will be immediately accretive to CloudMD with synergies the company believes will drive further revenue and increased EBITDA margin through cost savings achieved through the scaling of operations and by tapping into CloudMD's current health technology solutions that will be added to IDYA4’s current product portfolio.
공시 • Nov 20CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Re:Function Health Group Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8.3 million on August 19, 2020. As of November 9, 2020, CloudMD Software & Services signed a definitive share purchase agreement to acquire Re:Function Health Group Inc. As per terms, consideration is paid in the form of CAD 3 million in cash, subject to a working capital adjustment, CAD 3.5 million in the form of issue of common shares and CAD 1.5 million earn out which is payable in shares of CloudMD in annual issuances over a period of three years. The shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. As per the approval, consideration paid CAD 3 million in cash, 3.977272 million of common shares, and 1.704546 million common shares in the form of performance based earn out. Ralph Cheesman and Mike Smith will be joining CloudMD to lead the continued expansion of allied health services across North America. Re:Function group of clinics generated approximately CAD 5.8 million in revenues with earnings before interest, taxes, depreciation and amortization margins exceeding 19% over the last fiscal year ending January, 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. As of November 12, 2020, TSX Venture Exchange has accepted for filing a Binding Term Sheet. The company anticipates a definitive agreement on or before September 18, 2020. The acquisition will be immediately accretive to CloudMD. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Re:Function Health Group Inc on November 19, 2020.
공시 • Nov 10CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 32.4 million.CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 32.4 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 13,500,000 Price\Range: CAD 2.4 Discount Per Security: CAD 0.168
공시 • Oct 29CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet to acquire HumanaCare Inc. for CAD 17.5 million on October 28, 2020. As part of the consideration, CloudMD has agreed to pay (i) CAD 6.3 million in cash, subject to a working capital adjustment, (ii) CAD 6.825 million in common shares of the CloudMD and (iii) a performance-based earnout of CAD 4.375 million, which is payable in common shares of the CloudMD in equal annual issuances over a period of two years. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. Upon closing, the acquisition of HumanaCare will be immediately accretive to CloudMD with synergies the CloudMD believes will drive further revenue and increased EBITDA margin through cost savings achieved through scaling of operations and by tapping into CloudMD’s network of counsellors, nurses and other healthcare professionals.
공시 • Oct 20+ 1 more updateCloudMD Software &Services Inc. Appoints Mena Beshay as Global Head, Corporate DevelopmentCloudMD Software &Services Inc. announced that it has appointed Mena Beshay, the Company's current Chief Financial Officer ("CFO"), to a newly created, more focused role of Global Head, Corporate Development, where he will be responsible for leading the Company's corporate development activities which includes global mergers and acquisitions ("M&A") and its organic growth strategy. Mena's financial and operational experience will be valuable in leading the execution of the Company's growth strategy, while putting an even greater emphasis on M&A.
공시 • Oct 16CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Snapclarity Inc.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Snapclarity Inc. for CAD 6.8 million on July 16, 2020. CloudMD Software & Services Inc. has signed an Amalgamation Agreement to acquire Snapclarity Inc. on September 22, 2020. Total consideration payable by CloudMD in connection with the acquisition is CAD 3.35 million, subject to certain holdbacks, payable as up to CAD 0.98 million in cash and up to CAD 2.38 million in shares of CloudMD. All shares issued pursuant to the acquisition are subject to a two year release. Additionally, subject to the achievement of certain performance conditions in 2021 and 2022, Snapclarity may earn an additional CAD 3.65 million in equity-based consideration. Snapclarity will amalgamate with a wholly-owned subsidiary of CloudMD and upon completion of the Amalgamation, the amalgamated corporation will be a wholly-owned subsidiary of CloudMD. The Amalgamation is subject to Snapclarity shareholder approval. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before August 14, 2020. The transaction is expected to close before September 30, 2020. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of Snapclarity Inc. on October 15, 2020.
공시 • Oct 10CloudMD Software & Services Launches CloudMD On Demand, a National, Online Telemedicine Service for Pharmacies, Insurance Companies and EmployersCloudMD Software & Services Inc. announced the launch of a new service: CloudMD On Demand, an online, virtual care service for companies, insurers and pharmacies to offer their customers easier, more convenient access to virtual telemedicine. CloudMD OnDemand aims to provide turnkey and readily accessible virtual healthcare options to enterprise level partners. Through the offering, CloudMD develops a white-labeled, customizable landing page where individuals can get access to a doctor on demand for non-emergency medical appointments. This offering is especially important for employers, insurance providers and pharmacies, who have been instrumental in the development of this service. In addition, corporations with e-commerce websites can streamline the process for customers to see a doctor online and refill a prescription for pick up at a pharmacy location of their choice, or have it delivered directly to their doorstep. COVID-19 has increased the need for access to care through digital platforms, and employers are looking for evidence based, outcome-oriented solutions that will offer virtual healthcare for employees and their family members. Equally important is that the healthcare provided virtually, is delivered by physicians with the same level of patient care compared to an in person visit in a clinic. CloudMD uses public healthcare resources to ensure the highest quality of care and treatment plans for patients. The availability of the on-demand service is important for partners to continue managing the wellbeing of their customers and employees. The on-demand platform also eliminates the disruption in continuity of care caused by limited healthcare resources due to the pandemic. Patients are able to receive cost effective and efficient care, while empowering them to take control of their healthcare.
공시 • Sep 29CloudMD Software & Services Inc. (TSXV:DOC) entered into a Binding Term Sheet to acquire 87.5% stake in Benchmark Systems, Inc. from Antworks Pte. Ltd. for $4.4 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a Binding Term Sheet to acquire 87.5% stake in Benchmark Systems, Inc. from Antworks Pte. Ltd. for $4.4 million on September 28, 2020. As per the terms, CloudMD will pay $4.4 million in cash. AntWorks will retain a 12.5% equity stake in Benchmark. As a minority holder of Benchmark, AntWorks will continue to work with CloudMD providing expertise in global hyper automation and AI and provide access to cutting edge AI technologies. In the fiscal year ending March 31, 2020, Benchmark generated approximately $4.9 million in revenues. Approximately 80% of revenue was SAAS based, recurring revenue. EBITDA is 13% annually from SAAS based, recurring revenue. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement. CloudMD anticipates a definitive agreement on or before October 15, 2020. The purchase of Benchmark will be immediately accretive to CloudMD and provides a number of opportunities for optimization to drive further revenue.
공시 • Sep 26+ 1 more updateCanada Health Infoway and CloudMD Partner to Give More Canadians Access to e-PrescribingCanada Health Infoway (Infoway) and CloudMD announce that they have reached an agreement to advance e-prescribing in Canada. PrescribeIT® is Infoway's national e-prescribing service that enables prescribers and pharmacists to electronically create, receive, renew and cancel prescriptions, while improving overall patient care through secure clinician messaging. Under the agreement, CloudMD will integrate its Juno electronic medical record (EMR) with PrescribeIT's solution infrastructure. Cloud MD is aiming to have the technical work completed in early 2021. Once complete, physicians and nurse practitioners who offer virtual consultations with patients will be able to send prescriptions electronically from their EMR to the patient's pharmacy of choice, and pharmacies will be able to request prescription renewals electronically from the patient's prescriber. CloudMD provides virtual medical care to a combined network of 376 clinics, more than 3,000 licensed practitioners and almost three million patients through its technology components.
공시 • Sep 24CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 18.078 million.CloudMD Software & Services Inc. has completed a Follow-on Equity Offering in the amount of CAD 18.078 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 13,100,000 Price\Range: CAD 1.38 Discount Per Security: CAD 0.0966
공시 • Sep 18CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding agreement to acquire Chronic Care Medical Clinic.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding agreement to acquire Chronic Care Medical Clinic on August 5, 2020. The acquisition is subject to customary closing conditions and receipt of TSX Venture Exchange approval. Terms of the agreement will be disclosed upon signing of the definitive agreement. CloudMD Software & Services anticipates closing of the acquisition on or before September 8, 2020.
공시 • Aug 25CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire Re:Function Health Group Inc for CAD 8 million on August 24, 2020. As per terms, consideration is paid in the form of CAD 3 million in cash, CAD 3.5 million in the form of issue of common shares and CAD 1.5 million earn out which is payable in shares of CloudMD in annual issuances over a period of three years. The shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance. Ralph Cheesman and Mike Smith will be joining CloudMD. Re:Function group of clinics generated approximately CAD 5.8 million in revenues with earnings before interest, taxes, depreciation and amortization margins exceeding 19% over the last fiscal year ending January, 2020. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture Exchange approval. The company anticipates a definitive agreement on or before September 18, 2020. The acquisition will be immediately accretive to CloudMD.
공시 • Aug 06CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of South Surrey Medical Inc.CloudMD Software & Services Inc. (TSXV:DOC) signed a binding term sheet agreement to acquire South Surrey Medical Inc. for CAD 0.7 million on June 11, 2020. The parties entered into a share purchase agreement on July 28, 2020. CloudMD Software & Services Inc. has agreed to pay an aggregate consideration of up to CAD 0.7 million payable as up to CAD 0.2 million in cash and up to CAD 0.5 million in shares of CloudMD Software & Services Inc., a portion of which is subject to the achievement of certain performance conditions, and a customary working capital adjustment. All shares issued pursuant to the acquisition are priced at the ten-day volume weighted trading price of the Company shares for the 10 trading days prior to the execution of the definitive agreement. South Surrey Medical generated revenue of CAD 3 million in the latest fiscal year ended December 31, 2019. South Surrey Medical operates with 24 healthcare professionals. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD Software & Services Inc. anticipates a definitive agreement on or before July 31, 2020. As on July 28, 2020, CloudMD anticipates closing of the acquisition on or before July 31, 2020. CloudMD Software & Services Inc. (TSXV:DOC) completed the acquisition of South Surrey Medical Inc. on August 5, 2020.
공시 • Jul 30CloudMD Software & Services Inc. (CNSX:DOC) acquired Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd.CloudMD Software & Services Inc. (CNSX:DOC) acquired Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd. on July 17, 2019. CloudMD Software & Services Inc. (CNSX:DOC) completed the acquisition of Cloverdale Pharmacy Ltd./ Steveston Health Centre Ltd. on July 17, 2019.
공시 • Jun 17CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical for CAD 0.2 million.CloudMD Software & Services Inc. (TSXV:DOC) entered into a binding term sheet to acquire 51% stake in West Mississauga Medical for CAD 0.2 million on June 16, 2020. Under the terms of consideration, CAD 0.14 millions payable in cash and CAD 0.06 million in shares of CloudMD Software & Services Inc. West Mississauga Medical generated more than CAD 1.8 million in revenues. The acquisition is subject to customary closing conditions, including the execution of a definitive acquisition agreement and receipt of TSX Venture exchange approval. CloudMD anticipates a definitive agreement on or before July 31, 2020. The acquisition will be immediately accretive to CloudMD.